HAL 5% with illumination: Clinical Trials

2 trials of HAL 5% with illumination, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Not yet recruiting 1

Follow HAL 5% with illumination: new trials by email Literature Review of HAL 5% with illumination trials Research Report on HAL 5% with illumination

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hexaminolevulinate Photodynamic Therapy (HAL-PDT) With Deferred Surgery Versus Surgery for High-grade Squamous Intraepithelial Lesions (HSIL)
Loop Electrosurgical Excision Procedure (LEEP) or Cold Knife Conization (CKC), HAL 5% with illumination - Cervical Intraepithelial Neoplasia, Papillomavirus Infections
Phase 2Not yet recruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University2302026-07-012026-07-09
Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical Neoplasia
HAL 5% with illumination, HAL 1% with illumination, HAL 0.2% with illumination - Cervical Intraepithelial Neoplasia
Phase 2CompletedPhotocure2622011-04-012016-05-16

Conditions studied

Uterine Cervical Dysplasia (2)  ·  Papillomavirus Infections (1)  ·  Squamous Intraepithelial Lesions (1)

Sponsors

Photocure (1)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)

Countries

China (1)  ·  Germany (1)  ·  Norway (1)

Top investigators

Peter Hillemanns, MD, PhD (1)

Results publications

PMID 25467012